Theravance Biopharma TBPH

$ 16.55 -0.3%

Annual report 2025
added 03-23-2026

Theravance Biopharma DIO Ratio 2011-2026 | TBPH

Annual DIO Ratio Theravance Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	1.02 K	1.54 K	784	1.13 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.54 K	784	1.12 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	ACADIA Pharmaceuticals ACAD	295	$ 22.57	0.04 %	$ 3.74 B	USA
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Akebia Therapeutics AKBA	147	$ 1.41	-1.4 %	$ 363 M	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Aytu BioScience AYTU	209	$ 2.56	-3.76 %	$ 16.1 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 20.87	2.3 %	$ 976 M	USA
	Aquestive Therapeutics AQST	120	$ 4.17	-0.24 %	$ 446 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Arcutis Biotherapeutics ARQT	185	$ 24.57	-0.16 %	$ 3.13 B	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA